The Effect of Exposure to Aversive Non-verbal Vocalizations on Pain Tolerance
Launched by CENTRE HOSPITALIER UNIVERSITAIRE DE SAINT ETIENNE · Jun 8, 2020
Trial Information
Current as of August 19, 2025
Recruiting
Keywords
ClinConnect Summary
This clinical trial is investigating how certain sounds, like shouting or screaming, can affect how much pain a person can tolerate. Researchers want to understand how these non-verbal vocalizations influence pain levels in healthy adults. The trial is currently recruiting participants aged between 65 to 74 years and also those between 21 to 914 years, and is open to all genders.
To be eligible, participants should be in good health and have access to social security. However, individuals with certain conditions, such as chronic pain, heart problems, diabetes, or neurological issues, will not be able to take part. If you join the study, you will receive detailed information about what to expect and will need to sign a consent form. This trial aims to shed light on how our reactions to sounds can impact our experiences of pain, which could have important implications for understanding human behavior and health.
Gender
ALL
Eligibility criteria
- Inclusion Criteria:
- • Participant in good health
- • Affiliated or entitled participant in a social security scheme
- • Participant who received informed information about the study and co-signed, with the investigator, a consent to participate in the study
- Exclusion Criteria:
- • Chronic pain
- • High blood pressure or poor circulation
- • Cardiac or vascular disease, or a heart condition (including symptoms of Raynaud's syndrome)
- • Allergy or hypersensitivity to cold
- • Diabetes
- • Epilepsy
- • Pregnancy
- • Recent serious injury
- • Neurological or psychiatric condition known to affect pain tolerance (e.g., peripheral neuropathy, schizophrenia)
- • History of fainting or seizures
- • History of frostbite
About Centre Hospitalier Universitaire De Saint Etienne
The Centre Hospitalier Universitaire (CHU) de Saint-Étienne is a leading academic medical center in France, dedicated to advancing healthcare through innovative clinical research and high-quality patient care. With a robust infrastructure that supports a wide range of medical specialties, CHU de Saint-Étienne fosters collaboration between healthcare professionals, researchers, and academic institutions. The center is committed to conducting rigorous clinical trials that adhere to ethical standards and regulatory requirements, aiming to improve treatment outcomes and enhance the overall health of the community. Through its dedication to scientific excellence and patient-centered care, CHU de Saint-Étienne plays a pivotal role in the advancement of medical knowledge and the development of new therapeutic interventions.
Contacts
Jennifer Cobb
Immunology at National Institute of Allergy and Infectious Diseases (NIAID)
Locations
Saint étienne, , France
Patients applied
Trial Officials
Roland PEYRON, MD
Principal Investigator
CHU SAINT-ETIENNE
Timeline
First submit
Trial launched
Trial updated
Estimated completion
Not reported
Similar Trials